Calpain activation and progression of inflammatory cycles in Parkinson’s disease
Parkinson’s disease (PD) is a progressive, neurodegenerative condition of the central nervous system (CNS) affecting 6.3 million people worldwide with no curative treatments. Current therapies aim to mitigate PD’s effects and offer symptomatic relief for patients. Multiple pathways are involved in t...
Main Authors: | Andrew Gao, Hannah M. McCoy, Vandana Zaman, Donald C. Shields, Naren L. Banik, Azizul Haque |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-01-01
|
Series: | Frontiers in Bioscience-Landmark |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/FBL/27/1/10.31083/j.fbl2701020 |
Similar Items
-
Inhibition of Calpain Attenuates Degeneration of Substantia Nigra Neurons in the Rotenone Rat Model of Parkinson’s Disease
by: Vandana Zaman, et al.
Published: (2022-11-01) -
Age-dependent neurodegeneration and neuroinflammation in a genetic A30P/A53T double-mutated α-synuclein mouse model of Parkinson's disease
by: Lisa Rauschenberger, et al.
Published: (2022-09-01) -
T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
by: Meena S. Subbarayan, et al.
Published: (2020-08-01) -
Post‐inflammatory administration of N‐acetylcysteine reduces inflammation and alters receptor levels in a cellular model of Parkinson's disease
by: Zeynep Bengisu Kaya, et al.
Published: (2023-07-01) -
Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology
by: Jun Sung Park, et al.
Published: (2023-12-01)